Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
13:33:25 EDT Tue 17 Jun 2025
Enter Symbol
or Name
USA
CA



Z:NBY - NOVABAY PHARMACEUTICALS INC - https://investors.novabay.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
NBY - Z1.00.60·0.6290.20.6293+0.02934.94.22360.6148  0.6297  0.60013.14  0.361112:58:47May 1515 min RT 2¢

Recent Trades - Last 10 of 36
Time ETExPriceChangeVolume
12:58:47Z0.6010.00125
12:56:49Z0.6010.0011
12:51:46Z0.6150.01528
12:50:13Z0.6290.02950
12:39:42Z0.6010.0012
12:37:35Z0.6010.00129
12:35:36Z0.62970.02972
12:24:00Z0.6290.02915
12:15:35Z0.6010.0014
12:08:28Z0.6290.02915

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-05-15 14:19U:NBYSEDAR Interim Financial StatementsSEDAR Interim MD & A
2025-04-04 20:36U:NBYSEDAR Audited Annual Financial StatementsSEDAR MD & A
2025-04-04 20:31U:NBYSEDAR Annual Information FormSEDAR Annual Information Form
2025-03-07 06:50U:NBYNews ReleaseNovaBay Pharmaceuticals to Hold Special Meeting of Stockholders
2025-01-23 08:00U:NBYNews ReleaseNovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal
2024-12-19 06:50U:NBYNews ReleaseNovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders
2024-12-09 06:50U:NBYNews ReleaseNovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting
2024-11-22 16:05U:NBYNews ReleaseNovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024
2024-11-15 08:00U:NBYNews ReleaseProminent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals' Proposals to Authorize the Sale of its Avenova Brand
2024-11-07 17:04U:NBYSEDAR Interim Financial StatementsSEDAR Interim MD & A
2024-11-07 16:05U:NBYNews ReleaseNovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results
2024-11-06 16:05U:NBYNews ReleaseNovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price
2024-10-29 08:00U:NBYNews ReleaseNovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC
2024-09-20 08:30U:NBYNews ReleaseAcumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay Pharmaceuticals
2024-09-20 08:00U:NBYNews ReleaseNovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets
2024-08-13 17:52U:NBYSEDAR Interim MD & ASEDAR Interim Financial Statements
2024-08-13 16:05U:NBYNews ReleaseNovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results
2024-08-01 06:50U:NBYNews ReleaseNovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024
2024-07-30 06:50U:NBYNews ReleaseNovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales
2024-07-29 16:05U:NBYNews ReleaseNovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option